Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center.
about
Autophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseasesIdentification of liver fibrosis in HIV/HCV-coinfected patients using a simple predictive model based on routine laboratory data.Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease.LecT-Hepa facilitates estimating treatment outcome during interferon therapy in chronic hepatitis C patients.Hepatitis C: magnitude of the problem.The history of the "natural history" of hepatitis C (1968-2009).Association of γ-glutamyl transferase (GGT) activity with treatment and clinical outcomes in chronic hepatitis C (HCV).Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients.Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C.Clinical outcomes in a prospective study of community-acquired hepatitis C virus infection in Northern Norway.Total and cause-specific mortality rates in a prospective study of community-acquired hepatitis C virus infection in northern Norway.Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center study.Hepatitis C virus infection was not found in patients with sporadic porphyria cutanea tarda, membranoproliferative glomerulonephritis or membranous glomerulonephritis in Northern Norway.Long-term effect of interferon alpha-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis.Probability of liver cancer and survival in HCV-related or alcoholic-decompensated cirrhosis. A study of 377 patients.The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C.
P2860
Q26992256-E0CD2167-AC28-4A67-8151-3493F37A7DC2Q31139499-2DDB2054-F259-44B5-AA19-449F438C308FQ34605692-D75CC6FB-FD6E-483A-B3FE-0E86576B6351Q34769512-C2AB8574-5479-404E-8D05-5F7E653CF259Q34936115-7822C90E-5A91-45A7-9803-5741205EC120Q35216592-696C1889-91E0-4C2D-AB97-16BC3606AFBBQ36759370-102A3D3C-598E-400C-BCC0-E9D67B027C1EQ38504802-6BD0908F-64BC-47FF-80F1-FA904EE2DB3CQ39624673-2AFF8865-C659-4E29-966B-9C61C8A79D00Q39826805-101E27C9-375C-4039-BEF6-C858F74F247EQ39894712-E41D305F-D7B2-49EA-82A7-83640DED744DQ43757135-FC4B4F17-0F3A-4F10-9B75-541CBAFAAC3FQ45361548-6E45F337-CEA8-4775-91B2-FB47B6B802D5Q45386114-C1DAE5C6-8B6C-4223-927A-87C833D91807Q45414516-E988D851-2B2F-4E1B-AAE3-F6303B1C3AB2Q46899599-88531C44-F8BD-4FBA-911B-8D2FA7306626Q50583619-C68CD1E7-766A-48F8-BE1F-79699777E043
P2860
Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Long-term follow-up of chronic ...... sed at a tertiary-care center.
@en
Long-term follow-up of chronic ...... sed at a tertiary-care center.
@nl
type
label
Long-term follow-up of chronic ...... sed at a tertiary-care center.
@en
Long-term follow-up of chronic ...... sed at a tertiary-care center.
@nl
prefLabel
Long-term follow-up of chronic ...... sed at a tertiary-care center.
@en
Long-term follow-up of chronic ...... sed at a tertiary-care center.
@nl
P2093
P1476
Long-term follow-up of chronic ...... osed at a tertiary-care center
@en
P2093
A Sánchez-Fueyo
J M Sanchez-Tapias
M Bruguera
S Ampurdanès
P304
P356
10.1016/S0168-8278(01)00088-5
P577
2001-08-01T00:00:00Z